NCT01417104View on ClinicalTrials.gov

Aliskiren Effect on Aortic Plaque Progression

PHASE2/PHASE3TerminatedINTERVENTIONAL

Enrollment

71

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

December 31, 2011

Study Completion Date

January 31, 2012

Conditions

Atherosclerosis

Interventions

DRUG

Aliskiren

150 mg/300mg

DRUG

Placebo

150mg/300mg

Trial Locations (1)

43210

Ohio State University, Columbus

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Novartis

INDUSTRY

lead

Ohio State University

OTHER